Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “etanercept” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 8
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 8 pipeline programs matching "etanercept" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

8 results for “etanercept” Back to intelligence hub

Search results

  1. Etanercept

    Coherus Oncology

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial
  2. Etanercept

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial
  3. Etanercept

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial
  4. prefilled liquid etanercept(Yisaipu)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Ankylosing Spondylitis

    phase 3 small molecule completed

    1 trial
  5. Etanercept

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Discoid

    phase 2 small molecule completed

    1 trial
  6. Etanercept

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 1 small molecule active

    1 trial
  7. Etanercept

    Pfizer

    Moderate to Severe Psoriasis

    approved small molecule completed

    1 trial
  8. Etanercept , Methotrexate

    Wyeth is now a wholly owned subsidiary of Pfizer

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.